To extend the finding that oncogenic PIK3CA mutants sensitize cells to a reduction in RNMT, RNMT knockdown was performed in three more breast cancer cell lines (HCC38, HCC1569 and HCC1500) and one lung carcinoma cell line (NCI-H460). Here, RNMT is linked to breast cancer.